Semaglutide News and Research

Latest Semaglutide News and Research

The importance of muscle preservation in medically induced weight loss

The importance of muscle preservation in medically induced weight loss

Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity

Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity

Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery

Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery

Semaglutide may reduce Alzheimer's risk in diabetics

Semaglutide may reduce Alzheimer's risk in diabetics

Semaglutide may lower Alzheimer's risk in type 2 diabetes patients

Semaglutide may lower Alzheimer's risk in type 2 diabetes patients

Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients

Rise in weight-management glucose-lowering drug prescriptions in type 1 diabetes patients

Study highlights life-saving potential of access to effective obesity treatments

Study highlights life-saving potential of access to effective obesity treatments

Diabetes drugs may reduce risk of opioid overdose and alcohol intoxication

Diabetes drugs may reduce risk of opioid overdose and alcohol intoxication

New PET scan effectively detects benign insulinomas in the pancreas

New PET scan effectively detects benign insulinomas in the pancreas

New guidelines focus on preventing first strokes through healthy living

New guidelines focus on preventing first strokes through healthy living

Cost-effectiveness of combining weight loss drugs and surgery

Cost-effectiveness of combining weight loss drugs and surgery

Researchers develop strategies to identify regulators of intestinal hormone secretion

Researchers develop strategies to identify regulators of intestinal hormone secretion

Ozempic and similar drugs may lower risks for opioid and alcohol use disorders

Ozempic and similar drugs may lower risks for opioid and alcohol use disorders

GLP1R medications show promise in reducing suicidal ideation among adolescents with obesity

GLP1R medications show promise in reducing suicidal ideation among adolescents with obesity

Expanding access to GLP-1 weight-loss drugs could save thousands of lives

Expanding access to GLP-1 weight-loss drugs could save thousands of lives

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Dietitians boost GLP-1 therapy success with personalized care and side effect management

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models

Semaglutide enhances cognitive abilities and reduces Alzheimer’s pathology in mice and human brain models

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

Semaglutide improves heart health and reduces weight in obese patients, but with side effects

Promising new treatment strategy for type 2 diabetes

Promising new treatment strategy for type 2 diabetes

KFF Health News' 'What the Health?': Yet another promise for long-term care coverage

KFF Health News' 'What the Health?': Yet another promise for long-term care coverage

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.